Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020

FDA recall notice · announced May 22, 2019 · D.b.p. Distribution

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020

Reason for recall

Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.

Notes

Distribution: Nationwide.
Lot/code information: Expiration 12/29/2020
Quantity: unknown
Status: Terminated
Products in this recall event:
- Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020 (D-1292-2019)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.